Search Results

Medtronic's Arc Support Catheter Launched for Solitaire Stent Retriever in Acute Ischemic Stroke Treatment

September 17, 2015—Medtronic plc announced the United States launch of its Arc support catheter.

FDA Clears Reverse Medical's ReCruit Microcatheter for Neurointerventional Procedures

August 14, 2009—Reverse Medical Corporation (Irvine, CA) announced that it has received US Food & Drug Administration 510(k) clearance for its ReCruit microcatheter, which is intended to retrieve intravascular foreign objects during interventional procedures, including from the neurovasculature.

Toro Neurovascular’s Toro 88 Superbore Catheter Cleared by FDA 

March 11, 2026—Toro Neurovascular announced FDA 510(k) clearance and commercial introduction of the Toro 88 superbore catheter, a neurovascular access catheter platform.

Stryker’s Target Tetra Detachable Coil for Treating Small Aneurysms Cleared by FDA

December 15, 2022—Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform.

Reverse Medical ReFlex Catheter Cleared in US and Europe

April 26, 2011—Reverse Medical Corporation (Irvine, CA) announced that it has received US Food and Drug Administration 510(k) clearance to market the ReFlex line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery.

FDA Clears Balt's Optima Coil System for Neurovascular Procedures

March 20, 2018—Balt USA announced 510(k) clearance from the US Food and Drug Administration for the company's Optima coil system and the completion of the first clinical cases with the device in the United States, where a limited market release is now underway.

Rapid Medical’s Tigertriever to Be Studied for Cognitive Benefits in Treatment of Ischemic Stroke

January 29, 2025—Rapid Medical announced that the first patient has been enrolled in the company’s COGNITIVE study, which is evaluating a link between mechanical thrombectomy and cognitive improvement.

Cook Medical's Zilver PTX Stent Gains CE Mark to Treat SFA

August 11, 2009—Cook Medical (Bloomington, IN) announced that CE Mark approval has been granted for its Zilver PTX paclitaxel-eluting peripheral stent to treat severe blockages in the superficial femoral artery.